Antibodies against the first coronavirus strain aren’t very effective against emerging forms of the virus
While this isn't ideal news, it would be much worse if we didn't know.
While this isn't ideal news, it would be much worse if we didn't know.
It was safe and showed efficacy for 97% of the participants in the trial.
It's not ideal, but it's better than some expected.
An important step forward in the fight to eradicate Ebola.
Just 3% of the world's population has antibodies for COVID-19 -- woefully short of at least 60% required for herd ...
The antibodies were isolated a few years ago, but there was "no need for such a treatment" at the time.
It's good news for sufferers of epilepsy -- though novel treatments are still a while away.
Their nature makes them ideal against pathogens that hide from immune cells, such as HIV.
Mostly affecting those 60 years old and older, an estimated 7 to 10 million people worldwide have Parkinson's Disease.
Scientists from the Scripps Research Institute (TSRI) and Janssen Pharmaceutical Companies of Johnson & Johnson (Janssen) have discovered a way ...
© 2007-2023 ZME Science - Not exactly rocket science. All Rights Reserved.
© 2007-2023 ZME Science - Not exactly rocket science. All Rights Reserved.